Your browser doesn't support javascript.
loading
Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review.
Solares, I; Viñal, D; Morales-Conejo, M; Rodriguez-Salas, N; Feliu, J.
Afiliação
  • Solares I; Department of Internal Medicine, Reference Center for Inherited Metabolic Disease - MetabERN, University Hospital 12 de Octubre, UCM Madrid, Madrid, Spain.
  • Viñal D; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. Electronic address: dvinallozano@gmail.com.
  • Morales-Conejo M; Department of Internal Medicine, Reference Center for Inherited Metabolic Disease - MetabERN, University Hospital 12 de Octubre, UCM Madrid, Madrid, Spain; Grupo de Enfermedades Mitocondriales y Neuromusculares, Instituto de Investigación Hospital 12 de Octubre (i+12), Centro de Investigación Bioméd
  • Rodriguez-Salas N; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain; Translational Oncology Group, IdiPAZ, Madrid, Spain; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain; CIBERONC, Madrid, Spain.
  • Feliu J; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain; Translational Oncology Group, IdiPAZ, Madrid, Spain; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain; CIBERONC, Madrid, Spain.
ESMO Open ; 6(4): 100223, 2021 08.
Article em En | MEDLINE | ID: mdl-34388689

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 1 / Neurofibroma Plexiforme Tipo de estudo: Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 1 / Neurofibroma Plexiforme Tipo de estudo: Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article